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Abstract 
The management of wounds in patients on anticoagulant therapy who require oral 
surgical procedures is problematic and often results in a non-satisfactory healing process. 
Here we report a method to prepare an advanced dressing able to avoid uncontrolled 
bleeding by occluding the post-extractive alveolar wounds, and simultaneously, capable of 
a fast release of tranexamic acid (TA). Composite alginate/hyaluronan (ALG/HA) sponge 
dressings loaded with TA were prepared by a straightforward internal gelation method 
followed by a freeze-drying step. Both blank and drug-loaded sponges were soft, flexible, 
elegant in appearance and non-brittle in nature. SEM analysis confirmed the porous nature 
of these dressings. The integration of HA influenced the microstructure, reducing the 
porosity, modifying the water uptake kinetic and increasing the resistance to compression. 
TA release from ALG/HA sponges showed a controlled release up to 3h and it was faster 
in the presence of HA. Finally, an in vitro clotting test performed on human whole blood 
confirmed that the TA-loaded sponges significantly reduce the blood clotting index (BCI) 
by 30% compared to ALG/HA20 sponges. These results suggest that, if placed in a socket 
cavity, these dressings could give a relevant help to the blood hemostasis after dental 
extractions, especially in patients with coagulation disorders. 
 
Keywords 
Alginate; Biodegradable polymers; Controlled delivery; Wound healing; Mechanical 
properties. 
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1. Introduction 
Tooth extractions, even if considered as minor oral surgery, are one of the most 
routinely performed treatments among dental surgical techniques, and like all surgical 
procedures often cause large socket wounds, particularly after large tooth extraction. 
Under normal conditions the management of oral surgical wounds is simple, but for some 
category of patients, such as those on anticoagulant therapy, it is problematic and still 
controversial. Generally, when tooth extraction is required in such patients, the 
pharmacological therapy is reduced or stopped for several days before the surgery, 
increasing the risks of uncontrolled bleeding and, most of all, thromboembolism, which is 
considered a major complication1-3. However, a different approach based on the use of 
local hemostatic agents would make it possible to operate without any interruption or 
diminution of the anticoagulant treatment, avoiding risks caused by clogged blood flow due 
to suspending drug regimen4-6.  
The term "socket healing" generally refers to a series of local alterations that arise in 
both hard and soft tissues in order to close the socket wound after tooth extraction and to 
restore tissue homeostasis7. The most common complication following tooth extractions is 
the alveolar osteitis (dry socket) which may develop when an inflammation of the alveolar 
bone occurs, resulting in intense pain and delayed wound healing8,9. Dry socket is often a 
consequence of the removal or dissolution of the blood clot at the site of the tooth 
extraction before the wound has healed10. During tooth extraction, the formation of a blood 
clot is essential because it serves as a protective layer over the underlying bone and nerve 
endings in the empty tooth socket. The clot also provides the foundation for the growth of 
new bone and for the development of soft tissue. 
For this purpose, an advanced wound dressing able to control wound bleeding and 
enhance clot formation could be very useful for the prevention of alveolar osteitis and pain 
following tooth extraction. The wound dressing can act both as socket plug limiting the 
bleeding, but also as a local release platform for different drugs, including antifibrinolytics. 
In particular, the association of tranexamic acid (TA) with postoperative compression 
showed good results in preventing postoperative bleeding6,11. TA was already widely used 
as mouthwash12 or as socket irrigation immediately after extraction13 to prevent post 
extraction bleeding in patients on warfarin. However, this approach exhibits several 
limitations such as poor handiness and control over the delivered dose, as well as poor 
efficiency due to bleeding, which tends to quickly wash out the drug away from the 
administration site. 
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Macroporous alginate (ALG) sponges are considered a very interesting platform 
system for local drug release, and for this purpose, they have been extensively developed 
for a wide range of applications, such as bone tissue engineering, wound dressing and 
drug delivery14-16. Through the years ALG has gained a leading role among the wound 
dressing materials due to peculiar characteristics including the high absorbency and the 
promotion of healing and epidermal regeneration15. Its natural origin and simple extraction 
process from marine brown algae biomass, associated with their characteristics in term of 
biocompatibility and biodegradability under physiological conditions, make this 
polysaccharide ideal for use as socket-dressing materials17. Furthermore, it has been 
demonstrated that calcium alginate materials activate platelet and blood coagulation and 
for this reason, they have also been used as hemostatic dressings18.  
Common techniques for producing macroporous ALG dressings from a hydrogel or a 
polymer solution include air drying19, solvent evaporation20 or freeze-drying21. However, 
because of their hydrophilic polymeric backbones, ALG dressings easily dissolve in water 
unless radical, chemical or physical crosslinks are present. To overcome this limitation, 
internal gelation of ALG through CaCO3–GDL (d-glucono-δ-lactone) system has been 
recently proposed by our group as a versatile and straightforward strategy to obtain 
homogenous cross-linked composite ALG hydrogels22,23. In addition, we found that the 
integration of hyaluronan (HA), an extracellular glycosoaminoglycan extensively involved 
in all phases of wound healing24 and, in these ionically cross-linked ALG matrix has proved 
to be a versatile strategy to promote the wound healing process. Beside its function as the 
main component of extracellular matrix and cartilage, HA is also an important component 
of both soft periodontal tissues such as gingiva and periodontal ligament and of the hard 
tissue, such as alveolar bone and cementum. For these reasons, as recently reported by 
Casale et al.25, the topical application of HA could have a positive action on the healing of 
mineralized and non-mineralized tissues of the periodontium. Moreover, a recent pilot 
study in dogs demonstrated how HA may enhance bone formation and accelerate wound 
healing in infected sockets26. 
In this work, we present an alginate/hyaluronan (ALG/HA) based composite sponge 
dressing loaded with TA useful for reducing bleeding after tooth extraction and, at the 
same time, reducing the risk of alveolar osteitis. Moldable, biocompatible, and 
bioresorbable dressing were prepared by internal gelation followed by a freeze-drying to 
obtain solid macroporous sponges loaded with TA. The gradual release of calcium ions 
directly from the inside of an ALG solution results in a homogeneous crosslink, with 
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consequent improved mechanical properties, and allow an easy integration and a uniform 
distribution of drugs that are soluble in hydrogels or aqueous solutions. We examined in 
depth the behaviour of the sponges when they came in contact with simulated biological 
fluids, evaluating the swelling rates, the degradation behaviour and the drug release in 
relation to the composition and to the microstructure of the sponges. The mechanical 
properties and the adhesion profile on a simulated wound surface were also evaluated. 
Finally, the in vitro toxicity of the platform was tested in normal adult human primary 
epidermal keratinocyte cell lines and hemostatic efficacy evaluated through an in vitro 
dynamic whole blood clotting test. 
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2. Materials and methods 
2.1. Materials  
Sodium alginate (from Macrocystis Pyrifera, medium viscosity, 360 cps at 25°C) was 
purchased from Farmalabor (Italy). Hyaluronan (HA) sodium salt from Streptococcus equi 
(1.5–1.8 × 106 Da), Tranexamic acid (TA), d-glucono-δ-lactone (GDL), calcium chloride 
dihydrate, potassium chloride, sodium chloride, sodium phosphate dibasic, calcium 
carbonate and dimethylsulfoxide (DMSO) were obtained from Sigma–Aldrich (St. Louis, 
MO). Ethanol (laboratory grade) was purchased from Carlo Erba (Italy). Media, sera, and 
antibiotics for cell cultures were from ATCC (American Type Culture Collection, USA). 3-
(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) was obtained from 
Fisher Scientific (Leicestershire, UK). Deionized ultrafiltered water was used throughout 
this study. 
 
2.2. ALG/HA sponge preparation 
A 2% w/v ALG solution containing two different HA amount (10% or 20% of ALG 
weight to give ALG/HA10 and ALG/HA20, respectively) was prepared and gelled with a 
freshly prepared GDL solution as previously described27,28. To obtain TA-loaded ALG/HA 
sponges, TA was dissolved directly in the initial ALG/HA solution to give a final drug 
concentration of 2% (w/v). Solutions were cast in 24-well culture plate (1 mL) to form 
circular disks 5 mm in thickness and 15 mm in diameter. The well plates were capped, 
sealed with Parafilm®, and gelled on a horizontal surface at room temperature for 24 h. 
After gelation, the ALG disks were washed with deionized water, frozen overnight at 
−20°C, and then lyophilized at 0.01 atm and -60°C i n a Modulyo apparatus (Edwards, UK). 
The freeze dried sponges were stored at room temperature under vacuum.  
 
2.3. Physical characterization of sponge  
The bulk morphology of the ALG/HA sponge was analyzed through scanning electron 
microscopy (SEM). Samples were mounted on a metal stub by means of carbon adhesive 
tape and coated with a 20 nm thick gold/palladium layer with a modular high-vacuum 
coating system Emitech K575X. Images at different magnification were acquired using 
Quanta 200 FEG (FEI, USA) microscope. 
The average porosity of the ALG/HA sponge was determined by a fluid displacement 
method. Ethanol was chosen as the displacement liquid because it penetrates easily into 
the pores and did not induce shrinkage or swelling. The geometrical volume (Vs) of the 
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sponge samples was calculated by measuring diameter and height, and the pore volume 
(Vp) was measured by ethanol displacement method. The dry sponges (n = 3) were 
weighed (W0) and immersed in absolute ethanol at room temperature, and then placed in 
a degasser for 5 min to remove air bubbles from the sponge pores. After wiping gently with 
a filter paper to remove surface ethanol, samples were weighed immediately (We) to 
reduce ethanol evaporation. The porosity of the sponge was calculated according to 
equation 1: 
 
Porosity =
	

	
		100 = 	
	
	
		100     [Equation 1] 
 
where ρe represents the density of ethanol (0.789 g/cm3). An average value of five 
replicates for each sample was taken. 
The density (ρ) of the sponge was calculated according to the equation 2:  
 
 =

	
          [Equation 2] 
 
The pore mean diameters were calculated from the SEM images using the public 
domain Image J software (NIH, Bethesda, MD, USA). 
To measure the water retention rate, sponge samples (n = 3) were soaked in water 
for 30 min then carefully removed and placed in a centrifuge tube. The sponge was 
centrifuged at 3500 rpm for 3 min to eliminate the excess water, and the wet weight was 
recorded. Water retention rate (WR) was calculated according the equation 3 below: 
 
 =


		100        [Equation 3] 
 
Where Mh (g) is the weight of the sponge after centrifugation, and Md (g) is the initial 
dry weight. An average value of five replicates for each sample was taken. 
Thermogravimetric analysis (TGA) was performed to estimate the amount of residual 
moisture in the lyophilized sponges. Samples (n = 4) weighing between 3 and 6 mg were 
placed in a previously weighted 70 µL aluminum crucible and a dynamic phase of heating 
at a rate of 10°C/min from ambient temperature to 2 00°C was applied under a constant 
stream of dry nitrogen using a Thermal Advantage 2950 TGA system (TA Instruments, 
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Crawley UK). The percentage residual moisture was estimated from the weight loss using 
a TA Universal Analysis 2000 software. 
 
2.4. Mechanical properties and degradation behavior 
To investigate the resistance to deformation of the freeze-dried sponges a Texture 
Analyser (Stable Microsystems Ltd., Surrey, UK) equipped with 5 kg load cell and Texture 
Exponent-32® software program was employed. A 6-mm cylindrical stainless steel probe 
(P6 probe, Stable Microsystems Ltd., Surrey, UK) was used in compression mode. The 
resistance to deformation (‘hardness’) was investigated by compressing five ALG or 
ALG/HA sponges at three different locations to a depth of 2 mm at a speed of 1 mm/s 
using a trigger force of 0.001 N to determine the effects of HA on the force–time profiles 
during deformation by compression. 
The in vitro mucoadhesive properties of sponges were performed using the same 
apparatus but in tension mode. A 6.67% w/v gelatin solution was allowed to set as solid 
gel in a Petri dish (diameter 88 mm) and used to simulate a gingiva surface. The samples 
(n = 5) were attached to a 75 mm diameter probe using double-sided adhesive tape. 0.5 
mL of phosphate buffer saline (PBS, NaCl 120 mM, KCl 2.7 mM, Na2HPO4 10 mM) at pH 
7.4 supplemented with 2% (w/v) BSA were spread on gelatin to simulate a wet surface. 
The probe, lined with sponges, was set to approach the model wound surface with the 
following pre-set conditions: pre-test speed 0.5 mm/s; test speed 0.5mm/s; post-test speed 
1.0 mm/s; applied force 0,01 N; contact time 60.0 s; trigger type auto; trigger force 0.05 N 
and return distance of 10.0 mm23. The stickiness to the wound surface was calculated from 
the maximum force required to detach the sponge from the model surface and it is known 
as peak adhesive force (PAF). The total work of adhesion (TWA) was represented by the 
area under the force versus distance curve, whereas cohesiveness was defined as the 
distance traveled by sponge till detached and calculated using the Texture Exponent-32® 
software. 
 
2.5. Water uptake 
Water uptake was determined by placing the ALG/HA sponges in water. Three 
circular samples of 15 mm diameter were obtained from a 24-well culture plate. The initial 
weight of each sample was accurately recorded using an analytical balance, and then they 
were placed in 5 mL of water in a thermostatic bath at 37° C. Samples were taken out, 
excess water was carefully removed using tissue paper, and after being weighed were re-
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
immersed in water. The sample weight was recorded at intervals of 1 h up to 6 h and then 
every 24 h from there onwards until equilibrium was established. Water was replaced after 
every weight measurement. The percentage swelling ratio (SR %) at each time point was 
calculated using equation 4: 
 
%	 = 	


	× 	100         [Equation 
4] 
 
Where W is the mass of the swollen sample and W0 is the mass of the initial dry 
sample. The equilibrium water content (EWC) percent was calculated by equation 5: 
 
EWC	!%" = 	
		

	× 100         [Equation 5] 
 
Where We is the mass of the swollen sample at equilibrium and Wd is the mass of the 
dry sample at equilibrium. 
 
2.6. In vitro drug release 
The in vitro release profile of TA from ALG and ALG/HA sponge matrix was 
evaluated in PBS at pH 7.4. TA loaded sponges were incubated in 10 mL of PBS and 
placed in a thermostatic bath at 37° C. At schedule d time intervals, the release medium 
was withdrawn and replaced with the same volume of fresh medium. The supernatant was 
analyzed for TA content by an indirect method using a UV-vis spectrophotometer after 
derivatization with fluorescamine according the method described by El-Aroud et al.29. 
Briefly, TA samples were diluted 1:2 by volume in a fluorescamine solution at 0.5% (w/v) in 
ethanol and incubated in the dark at room temperature for 1 h before analysis. The 
absorbance of TA samples was measured at 390 nm using a Shimadzu 1800 
spectrophotometer (Shimadzu, Japan) fitted out with a 1 cm quartz cell (Hellma, 
Germany). The linearity of the response was verified over the concentration range 5–100 
µg/mL (r2≥0.999).  
 
2.7. Biocompatibility studies 
Cell viability studies were performed on normal adult human primary epidermal 
keratinocyte cells (ATCC PCS-200-011) cultured in a complete culture medium consisting 
of dermal cell basal medium (ATCC® PCS-200-030) plus one keratinocyte growth kit 
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(ATCC® PCS-200-040). The keratinocyte growth kit contains the following growth 
supplements: bovine pituitary extract (BPE), rhTGFα, L-glutamine, hydrocortisone 
hemisuccinate, insulin, epinephrine and apotransferrin. Furthermore, the medium was 
supplemented with 10 IU/mL of penicillin and 10 µg/mL of streptomycin. Cultures were 
maintained in humidified atmosphere of 95% air and 5% CO2 at 37°C. An indirect 
cytotoxicity assay was performed in accord with the international standard ISO 10993-530 
using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium 
reduction assay (details in supplementary information S1). 
 
2.8. In vitro dynamic whole blood clotting studies 
Human blood was collected from healthy volunteers (n = 5) and anti-coagulated with 
acid citrate dextrose tube (20 mM citric acid, 110 mM sodium citrate, 5 mM D-glucose). 
The blood clotting test was performed as described by Ong et al.31. Briefly, 300 µL of acid 
citrate dextrose (ACD)-whole blood was slowly dropped on the surface of a sponge 
dressing placed into a 50 mL polypropylene tubes. Once the sponges were completely 
covered, blood coagulation was triggered adding to the samples 24 µL of 0.2 M CaCl2 
solution followed by 10 min of incubation in a thermostatic incubator at 37°C under gentle 
shaking. Red blood cells (RBCs) that are not trapped in the clot were hemolyzed with 25 
mL of deionized water that was added by dripping water down the inside wall of the tubes 
without disturbing the clotted blood. The relative absorbance (A) of blood samples that had 
been diluted to 25 mL was been measured at 542 nm using a spectrophotometer (Infinite 
200, Tecan). The absorbance of 300 µL ACD-whole blood in 25 mL deionized water was 
assumed to be 100 as a reference value. The blood clotting index (BCI) of blank and drug 
loaded ALG and ALG/HA20 sponges was calculated by the equation 6. 
 
BCI =
%&&	'	!(	)*	+,))-	./01/	/2-	+334	04	1)45215	.05/	6278,3
(	)*	(9:	whole	+,))-	04	.253?
   [Equation 6] 
 
The BCI is correlated to the number of RBCs entrapped into the cloth, so as the BCI 
index raises, blood clotting decreases. 
 
2.9. Statistical analyses 
Statistical analyses were undertaken using GraphPad Prism®, version 6.00 
(GraphPad Software, La Jolla California USA, www.graphpad.). Data were compared 
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using a Student's t-test and a one-way ANOVA with Bonferroni post-test (parametric 
methods). 
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3. Results and Discussion 
3.1. Preparation and characterization of ALG and ALG/HA sponges 
Freeze-drying, which can prevent the destruction of the porous structure during the 
removal of water, was adopted in the preparation of crosslinked sponges starting from 
hydrogels obtained by internal gelation (Fig.1A). The freezing method is useful to obtain 
regular pore sizes since the sponge porosity is directly correlated with the size of the ice 
crystal formed during the freezing stage of the freeze-drying process21. In particular, Kang 
et al. demonstrated how the sponges prepared at freezing temperatures near -20 °C, 
develop a three-dimensional structure with interconnected pores without the use of any 
additives and organic solvents32. The ALG/HA sponges were imaged by SEM. The surface 
of ALG sponge exhibited a random highly porous structure with interconnected pores with 
a size in the range of 300−500 µm. This highly porous structure is of utmost importance to 
ensure water absorption and mechanical strength, especially if an application as socket 
dressing is envisaged. However, it is worth to notice that from SEM images the 
microstructure of the ALG sponge (Fig. 1B) appears slightly different from the one of the 
ALG/HA sponges (Fig. 1C-D). In particular, the micrographs of the sponge of ALG alone 
showed relatively thinner walls with a visible interconnecting pore networks below the 
surface, differently than the ALG/HA sponge. 
Water absorption (WA) and water retention (WR) are two very important properties 
for sponge materials, which are highly dependent on their inherent structure and 
morphology. Values of porosity (P), WA and WR for the various ALG/HA sponges are 
summarized in Table 1.  
The porosity, calculated with the fluid replacement method, were in agreement with 
the morphological characterization by SEM. In comparison with ALG/HA, the porosity in 
the ALG crosslinked sponges is significantly higher (p < 0.01 ALG/HA vs. ALG) suggesting 
a microstructure with deeper and interconnected pores. No significant differences in 
porosity were found between ALG/HA10 and ALG/HA20. Similarly, the presence of HA 
make the sponge significantly denser (p < 0.01 ALG/HA vs. ALG). In the ALG/HA 
sponges, HA partially fills the gaps between the ALG chains, and this could explain the 
difference in porosity despite the similar pore diameters. However, this difference in 
porosity does not have a significant effect on the final amount of water that this system can 
absorb, being the value of water absorption and EWC similar. By comparing WR values for 
ALG and ALG/HA sponges after centrifugation, we can see how the WR of ALG/HA 
sponges was similar to ALG sponge, despite the different composition and the high 
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hydrophilic character of HA33. In this case is probably the uniform and solid porous 
structure of crosslinked sponges that “lock” the water molecules and prevent the easy 
runoff of water.  
 
3.2. Mechanical properties 
A post extraction socket dressing should have specific mechanical properties to 
serve as a therapeutic device and, at the same time, as a mechanical obstruction to 
bleeding. Periodontal dressing materials should be slow-setting to allow manipulation and 
to create a smooth surface causing no irritation, should be flexible enough to withstand 
distortion and displacement, should be adhesive and coherent without being bulky, and 
must have the dimensional stability to prevent salivary leakage and plaque accumulation34. 
However, to date, there are no exact and standardized reproducible techniques to 
evaluate these properties. For this kind of dressing the resistance to deformation 
(hardness) is a valuable physical property that can affect the material clinical behavior both 
during the application and during its adaptation to the tissues. Fig. 2A shows how HA 
influences the resistance to deformation of the ALG/HA composite sponges. The addition 
of HA resulted in an increase in the ‘hardness’ with increasing concentration of HA and 
hence decreased the flexibility of the sponges.  
Another physical property evaluated in this study was the adhesive properties of the 
sponge dressings on a simulated wet gingival surface. A dressing with good adhesive 
properties is especially important not only for an easy placing and retention, but also 
considering its role in the prevention of microbial penetration. The adhesion profile was 
evaluated through measurement of the peak adhesive force (PAF), the total work of 
adhesion (TWA) and the cohesiveness, three parameters directly influenced by the 
physicochemical properties of the sponges such as the pore size distribution and the 
consequent hydration capacity35. In particular, PAF was used as a measure of the in vitro 
wound adhesive performance (Fig. 2B). The ALG sponges had a lower PAF (0.34 ± 0.1 N) 
compared to the ALG/HA20 (0.69 ± 0.06 N), with an increasing trend proportional to the 
presence of HA. The same increasing trend appears in WOA and cohesiveness. In 
general, adhesion properties depend on the hydration capacity of the porous materials 
where a more rapid initial hydration and consequent more rapid entanglement between the 
polysaccharide chains and the wound surface which causes a higher dressing adhesion. 
In this case, the differences in all the three parameters considered could be attributed to 
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the hydrophilic nature of HA which promotes the interaction between the sponges and the 
simulated wound environment probably due to the faster initial hydration. 
3.3. Water uptake and drug release from ALG/HA sponge 
The ability to absorb high amounts of fluids is essential to envisage a use of these 
systems as hemostatic dressings. Generally, for any advanced dressing an high 
absorption capacity is considered to be beneficial in all the applications where great 
amounts of biological fluids were produced15. Moreover, a dressing capable of a rapid 
absorption of plasma may also directly contribute to the hemostasis by trapping the 
anticoagulant factors, which are normally present into the blood stream. Because the 
dressings can rapidly absorb plasma, the anticoagulant factors are separated from whole 
blood, resulting in a quick clotting of blood cells by activating the inherent clotting system36. 
In case of drug loaded dressings, the drug release process is generally strictly related to 
the fluid absorption kinetic, which is in turn affected by sponge physical structure. For 
these reasons, the water absorption kinetics of ALG and ALG/HA sponges were carefully 
evaluated, and the results are shown in Fig. 3A.  
In contrast to EWC, the water absorption kinetics were influenced by the presence of 
HA in the sponge. The absorption curves of the ALG/HA hydrogels showed a higher rate 
of water uptake within the first 6 h of immersion (equilibrium swelling) as compared with 
ALG sponges, while after 24 h all the formulations displayed similar water uptake. 
However, a difference in porosity does not seem to be the main determinant to explain 
water uptake kinetics. Nevertheless, the high hydrophilic and polyanionic character of HA33 
may lead to an increase of the hydrostatic pressure within the sponge and enhance its 
hydration rate. 
The release of hydrophilic molecules from swellable sponges mainly depends on water 
uptake kinetics, thus pointing to the presence of HA as a key parameter in affecting the 
release rate. For application in bleeding wounds a fast release of the hemostatic agent 
from the dressing is an essential property, and for this reason, the impact of matrix 
composition on drug release from loaded sponges was investigated. TA, a drug with well 
know hemostatic properties, was loaded into the sponges and its release followed to 
evaluate the ability of the system to reduce bleeding upon wound application. The ALG 
sponge showed the slowest release rate, whereas the presence of HA accelerated it (Fig. 
3B). Comparison between the release profiles of TA and water uptake curves highlight that 
the water uptake reached over 70% of its final value in 3 h while in the same period almost 
95% of TA is released. Thus, the swelling process peaks in 6 h, when all TA has been 
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released. The incorporation of HA in the composite sponges significantly affected TA 
release profile because it causes a faster water absorption with a consequent larger burst 
effect. The faster water absorption also affects sponges degradation in vitro 
(supplementary materials S2). The behavior of the sponges when in contact with a 
simulated biological fluid is correlated with the HA concentrations (Fig. S1), whose 
presence leads to a faster loss of the three-dimensional structure. However, for ALG/HA 
sponges this loss of structural integrity occurred after 7 days from the contact, giving and 
appropriate contact time for ensure the drug release and a mechanical contribution to 
hemostasis. On this basis, ALG/HA20 providing the fastest TA release was selected for cell 
studies. 
 
3.4. Biocompatibility studies 
Cytotoxicity test is a fast method to screening medical devices and provide predictive 
evidence of material biocompatibility. Biocompatibility of ALG and ALG/HA sponges 
loaded with TA was evaluated on normal human keratinocytes which play an important 
role in cell migration during normal wound healing. Fig. 4 shows the effect of the sponges 
on the viability of keratinocyte cells assessed by indirect contact using a material extract 
previously conditioned with the samples to test. After indirect incubation of cells with the 
different sponges and the addition of the MTT dye, the formulations loaded with TA 
showed a toxicity profile not significantly different from the blank sponge, and the cell 
viability seems not to be influenced by the presence of HA and TA in the range of 
concentrations studied. All the formulation tested showed an initial cell mortality around 
80%, a value that can be considered acceptable. In fact, the recommended guidelines for 
in vitro cytotoxicity for medical devices and delivery systems such as wound dressings 
(DIN EN ISO 10993-5) specifies that such materials can be deemed non-cytotoxic for 
≥70% cell viability after exposure30. Therefore, the results obtained in the current study 
show that all the formulated sponge could be considerate as biocompatible and generally 
safe. 
 
3.5. Whole blood clotting studies 
The pro-coagulant properties of sponges loaded with TA were evaluated on ACD- 
human whole blood after 10 min of contact. After this time, the RBCs that were not trapped 
in the clot on the surface of dressing were hemolyzed and quantified using a 
spectrophotometer. In this case, higher absorbance values indicate a slower clotting rate. 
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As shown in Fig. 5, even when dispersed in ALG/HA sponges, TA was able to induce 
blood clotting. When human blood was incubated with TA loaded sponges the BCI was 
significantly reduced by 40% compared to negative control and by 30% compared to 
ALG/HA20 sponges. It has been already reported that HA can interfere with blood 
coagulation inhibiting platelet adhesion and aggregation and prolonging bleeding when 
administered systemically37 or when used as a coating for biomedical devices38. However, 
in TA-loaded sponges, this anticoagulant activity related to HA was not evident. Taken 
together these data demonstrate how using different concentration of HA, it was possible 
to modulate the mechanical and release characteristics of this composite sponge dressing 
preserving their pro-coagulant activity. 
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4. Conclusions 
The aim of this study was the development of a biocompatible dressing able to fit the 
tridimensional post extractive alveolar cavity, ensuring a pharmacological and mechanical 
contribution to the hemostasis. ALG/HA sponges loaded with TA were prepared in a two-
step procedure starting from a crosslinked hydrogel with a freeze-drying method. ALG/HA 
sponges with various HA contents showed a porous morphology with an interconnecting 
network and a pore size related to the amount of HA in the formulation. Swelling studies 
and texture analysis also confirmed the effect of HA on porosity and on water uptake that 
results in an improved adhesive properties and a fast drug release. Once confirmed the 
biocompatibility, a blood clotting test was successfully performed confirming the capacity 
of these sponges to have a direct action on blood clotting.  
Though further studies are needed to evaluate the in vivo blood clotting action of 
ALG/HA sponges, we can conclude that these dressings seem to be a very promising 
system for the management of uncontrolled bleeding in patients on anticoagulant therapy. 
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Table 1. Characteristics of ALG sponges. 
 
Fig. 1. Image of an ALG/HA20 sponge after freeze-drying (scale bar=1 cm) (A). SEM 
images of ALG (B), ALG/HA10 (C) and ALG/HA20 (D) (scale bar=1 mm). 
 
Fig. 2: Resistance to deformation (‘hardness’) (A), and adhesion profiles (B) of ALG and 
ALG/HA sponges. Hardness was evaluated compressing the sponges at three different 
locations, checking the resistance to compression for the different formulations. The 
adhesion properties are represented by peak adhesive force (PAF), work of adhesion 
(WOA) and cohesiveness. Data are shown as means of three independent experiments 
with SD indicated by the error bar. * p < 0.01, # p<0,05 vs ALG 
 
Fig. 3. (A) Kinetics of water uptake of ALG and ALG/HA sponges. (B) TA release profile 
from ALG and ALG/HA sponges in PBS pH 7.4. Results are reported as mean ± SD (n = 
3). 
 
Fig. 4. Effect of TA-loaded sponges on normal adult human primary epidermal 
keratinocyte cells viability. Cells (10,000 cells/well) have been seeded in 96-well culture 
plates in complete medium. The following day the cells have been incubated with the 
extraction media for 24, 48 or 72 h in a humidified incubator. Cell viability has been 
determined, as optical density, by MTT. The results have been reported as percentage of 
viable cells compared with cells incubated in modified dermal cell basal medium in the 
absence of ALG sponges, considered as 100% viable cells. Bars represent the mean ± 
standard deviation of triplicate determination in three independent experiments. 
  
Fig. 5. Effect of the ALG/HA20/TA sponge on BCI, as measured by absorbance of 
hemoglobin from lysed uncoagulated RBCs. The BCI is correlated to the number of RBCs 
entrapped into the cloth, so as the BCI index raises as blood clotting decreases. *** p < 
0.0001 vs CTR -, # p < 0.05 vs ALG/HA20 
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Porosity (%) Pore Diameters (µm) 
Density 
(mg/cm3) 
Water 
absorption (%) EWC (%) 
Water 
Retention (%) 
Residual 
moisture (%) 
ALG 56.61 ± 1.03 300 ± 70 30.76 ± 1.00 5103.95 ± 39.66 98.14 ± 0.02 75.4 ± 1.0 7.35 ± 0.03 
ALG/HA10 52.27 ± 3.21* 310 ± 14 34.74 ± 1.05* 4851.34 ± 63.77 98.08 ± 0.09 78.8 ± 4.1 7.38 ± 0.39 
ALG/HA20 47.70 ± 3.11* 320 ± 25 34.59 ± 1.85* 5070.04 ± 114.86 98.09 ± 0.07 77.1 ± 2.4 7.82 ± 0.31 
* p < 0.01 vs. ALG 
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